SMTI
Sanara MedTech Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Buy
+39/100
Last price
35.08
▲ 0.08 (0.23%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
34.97
Prev close
35.00
Day high
35.10
Day low
34.97
Volume
70.12K
Market cap
$322.32M
P/E (TTM)
—
52W range
16.05 – 35.34
Day trading desk
Gap from prior close
-0.09%
Prior close 35.00
VWAP
35.06
+0.05% from price
Relative volume
0.25×
Quiet session
Session range
0.37%
34.97 – 35.10
Position in range
85%
Near session high
ATR (14D)
0.20
0.56% of price
Prior day high
35.09
PDH
Prior day low
34.95
PDL
Bid / ask spread
—
Quote not published
Session volume
68.91K
Avg 276.85K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.17%
-2.1%
1M
+0.09%
-1.4%
3M
+46.90%
+43.5%
6M
+106.35%
+91.3%
YTD
+50.24%
+36.2%
1Y
+12.22%
-3.6%
3Y
+14.98%
-67.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on SMTI open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
4.40M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 4, 26 | NIXON RONALD THOMAS Director and Beneficial Owner of more than 10% of a Class of Security |
STOCK | 4.15K | $0 | Direct |
| Jun 4, 26 | TANZBERGER ERIC D Director |
STOCK | 5.31K | $0 | Direct |
| Jun 4, 26 | MYERS KEITH G Director |
STOCK | 4.38K | $0 | Direct |
| Jun 4, 26 | SALAMONE ANN BEAL Director |
STOCK | 4.15K | $0 | Direct |
| Jun 4, 26 | MAJOR ERIC D Director |
STOCK | 4.85K | $0 | Direct |
| Jun 4, 26 | ORTWEIN SARA N Director |
STOCK | 4.62K | $0 | Direct |
| Jun 4, 26 | DESUTTER ROBERT ANDREW Director |
STOCK | 5.54K | $0 | Direct |
| Jun 4, 26 | MACK ROSZELL III Director |
STOCK | 5.31K | $0 | Direct |
| Mar 20, 26 | WALDROP JACOB A. Chief Operating Officer |
STOCK | 13.96K | $0 | Direct |
| Mar 20, 26 | TAYLOR ELIZABETH Chief Financial Officer |
STOCK | 12.69K | $0 | Direct |
| Mar 20, 26 | YON SETH D Chief Executive Officer |
STOCK | 25.43K | $0 | Direct |
| Mar 20, 26 | MACKEY ASHLEY M Officer |
STOCK | 2.80K | $0 | Direct |
| Mar 20, 26 | MACKEY ASHLEY M Officer |
STOCK | 2.80K | $0 | Direct |
| Sep 15, 25 | YON SETH D Chief Executive Officer |
STOCK | 28.56K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
DESUTTER ROBERT ANDREW |
Director | 28.74K | Stock Award(Grant) |
MACK ROSZELL III |
Director | 21.84K | Stock Award(Grant) |
MCNEIL MICHAEL D. |
Officer | 32.52K | Stock Award(Grant) |
NIXON RONALD THOMAS |
Director and Beneficial Owner of more than 10% of a Class of Security | 3.48M | Stock Award(Grant) |
ORTWEIN SARA N |
Director | 25.41K | Stock Award(Grant) |
SALAMONE ANN BEAL |
Director | 26.86K | Stock Award(Grant) |
TANZBERGER ERIC D |
Director | 22.97K | Stock Award(Grant) |
TAYLOR ELIZABETH |
Chief Financial Officer | 17.63K | Stock Award(Grant) |
WALDROP JACOB A. |
Chief Operating Officer | 24.75K | Stock Award(Grant) |
YON SETH D |
Chief Executive Officer | 113.40K | Stock Award(Grant) |
Fundamentals
Market cap$322.32M
Enterprise value$354.68M
Revenue (TTM)$109.81M
Gross profit$102.16M
EBITDA$12.75M
Net income$-284.72K
EPS (TTM)$-0.04
Free cash flow$5.70M
Total cash$15.42M
Total debt$48.53M
Book value / share$0.86
Shares outstanding9.19M
Float3.77M
Short % of float5.80%
Dividend yield0.00%
Beta (5Y)1.19
Valuation & profitability ratios
Trailing P/E—
Forward P/E64.96
PEG ratio—
Price / sales—
Price / book40.60
EV / revenue3.23
EV / EBITDA27.83
Gross margin93.03%
Operating margin6.33%
Profit margin-29.15%
Return on equity-1.32%
Return on assets7.64%
Debt / equity611.63
Current ratio2.58
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $103.12M | $86.67M | $64.99M | $45.84M | — | +19.0% |
| Operating revenue | $103.12M | $86.67M | $64.99M | $45.84M | — | +19.0% |
| Cost of revenue | $7.52M | $8.14M | $7.85M | $6.36M | — | -7.6% |
| Gross profit | $95.60M | $78.53M | $57.14M | $39.48M | — | +21.7% |
| Research & development | $5.07M | $2.83M | $4.13M | $3.37M | — | +79.3% |
| Selling, general & admin | $78.72M | $71.67M | $56.99M | $45.98M | — | +9.8% |
| Total operating expense | $86.45M | $77.29M | $64.80M | $51.71M | — | +11.9% |
| Operating income | $9.15M | $1.24M | -$7.67M | -$12.23M | — | +635.0% |
| Net interest income | -$6.76M | -$3.11M | -$475.78K | $0 | — | -117.5% |
| Pre-tax income | -$393.12K | -$1.94M | -$4.44M | -$13.94M | — | +79.7% |
| Tax provision | — | — | $0 | -$5.84M | $0 | — |
| Net income | -$37.56M | -$9.66M | -$4.30M | -$7.94M | — | -288.7% |
| Net income to common | -$37.56M | -$9.66M | -$4.30M | -$7.94M | — | -288.7% |
| Basic EPS | -4.36 | -1.14 | -0.52 | -1.00 | — | -282.5% |
| Diluted EPS | -4.36 | -1.14 | -0.52 | -1.00 | — | -282.5% |
| EBIT | $6.37M | $1.19M | -$3.96M | -$13.94M | — | +434.6% |
| EBITDA | $10.31M | $6.11M | -$289.09K | -$11.57M | — | +68.7% |
| Basic shares | 8.62M | 8.48M | 8.28M | 7.91M | — | +1.6% |
| Diluted shares | 8.62M | 8.48M | 8.28M | 7.91M | — | +1.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $16.58M | $15.88M | $5.15M | $8.96M | +4.4% |
| Cash & short-term investments | $16.58M | $15.88M | $5.15M | $8.96M | +4.4% |
| Accounts receivable | $12.00M | $12.41M | $8.47M | $6.81M | -3.3% |
| Inventory | $3.95M | $2.75M | $4.72M | $3.55M | +43.4% |
| Total current assets | $33.54M | $33.31M | $19.01M | $20.62M | +0.7% |
| Property, plant & equipment | $2.53M | $1.88M | $3.25M | $2.22M | +34.7% |
| Goodwill & intangibles | $22.24M | $27.08M | $48.53M | $35.11M | -17.9% |
| Total assets | $72.94M | $88.09M | $73.87M | $61.04M | -17.2% |
| Total current liabilities | $18.63M | $15.29M | $13.77M | $12.81M | +21.8% |
| Current debt | — | — | $580.36K | — | — |
| Long-term debt | $45.97M | $30.69M | $9.11M | — | +49.8% |
| Total debt | $48.19M | $32.29M | $11.79M | $819.22K | +49.3% |
| Total liabilities | $67.01M | $49.18M | $29.28M | $19.32M | +36.3% |
| Retained earnings | -$75.30M | -$37.78M | -$28.04M | -$23.39M | -99.3% |
| Shareholder equity | $5.94M | $39.40M | $44.83M | $41.83M | -84.9% |
| Working capital | $14.92M | $18.02M | $5.24M | $7.81M | -17.2% |
| Net tangible assets | -$16.30M | $12.32M | -$3.70M | $6.72M | -232.3% |
| Shares issued | 8.95M | 8.75M | 8.54M | 8.30M | +2.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$37.57M | -$9.91M | -$4.44M | -$8.09M | -279.0% |
| Depreciation & amortisation | $3.95M | $4.92M | $3.68M | $2.37M | -19.8% |
| Stock-based compensation | $5.15M | $4.44M | $3.44M | $2.70M | +16.2% |
| Change in working capital | $972.97K | -$911.72K | -$3.28M | $517.62K | +206.7% |
| Operating cash flow | $6.79M | -$23.78K | -$3.25M | -$5.55M | +28,634.4% |
| Capital expenditure | -$4.65M | -$229.30K | -$265.25K | -$747.01K | -1,927.5% |
| Investing cash flow | -$14.97M | -$6.61M | -$10.21M | -$3.51M | -126.5% |
| Financing cash flow | $8.89M | $17.37M | $9.64M | -$627.35K | -48.8% |
| Free cash flow | $2.14M | -$253.08K | -$3.51M | -$6.30M | +944.6% |
| End cash position | $16.58M | $15.88M | $5.15M | $8.96M | +4.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $28.14M | $27.80M | $27.55M | $26.33M | $25.80M | +1.2% |
| Operating revenue | $28.14M | $27.80M | $27.55M | $26.33M | $25.80M | +1.2% |
| Cost of revenue | $1.98M | $1.92M | $1.87M | $1.87M | $1.94M | +3.0% |
| Gross profit | $26.16M | $25.87M | $25.67M | $24.46M | $23.87M | +1.1% |
| Research & development | $1.15M | $759.59K | $2.04M | $1.03M | $1.06M | +52.0% |
| Selling, general & admin | $22.60M | $21.88M | $20.08M | $19.88M | $19.63M | +3.3% |
| Total operating expense | $24.38M | $23.23M | $22.78M | $21.52M | $21.38M | +4.9% |
| Operating income | $1.78M | $2.65M | $2.89M | $2.94M | $2.49M | -32.7% |
| Net interest income | -$1.76M | -$1.79M | -$1.83M | -$1.82M | -$1.79M | +1.7% |
| Pre-tax income | -$411.14K | $397.69K | -$1.11M | $834.49K | $500.26K | -203.4% |
| Net income | -$452.86K | $458.96K | -$1.61M | -$30.41M | -$2.01M | -198.7% |
| Net income to common | -$452.86K | $458.96K | -$1.61M | -$30.41M | -$2.01M | -198.7% |
| Basic EPS | -0.05 | 0.05 | -0.19 | -3.52 | -0.23 | -200.0% |
| Diluted EPS | -0.05 | 0.05 | -0.19 | -3.52 | -0.23 | -200.0% |
| EBIT | $1.40M | $2.20M | $725.73K | $2.65M | $2.29M | -36.3% |
| EBITDA | $2.02M | $2.78M | $1.39M | $3.69M | $3.41M | -27.5% |
| Basic shares | 8.66M | 8.71M | 8.47M | 8.65M | 8.61M | -0.5% |
| Diluted shares | 8.66M | 8.99M | 8.47M | 8.94M | 8.61M | -3.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $15.42M | $13.59M | $16.58M | $14.94M | $16.96M | +13.4% |
| Cash & short-term investments | $15.42M | $13.59M | $16.58M | $14.94M | $16.96M | +13.4% |
| Accounts receivable | $12.57M | $13.62M | $12.00M | $12.09M | $11.99M | -7.7% |
| Inventory | $3.46M | $3.12M | $3.95M | $3.39M | $3.51M | +10.9% |
| Total current assets | $32.20M | $31.20M | $33.54M | $31.23M | $33.67M | +3.2% |
| Property, plant & equipment | $2.34M | $2.45M | $2.53M | $2.57M | $9.99M | -4.8% |
| Goodwill & intangibles | $20.88M | $21.46M | $22.24M | $24.70M | $44.59M | -2.7% |
| Total assets | $69.15M | $69.28M | $72.94M | $71.09M | $98.77M | -0.2% |
| Total current liabilities | $12.49M | $13.70M | $18.63M | $17.36M | $14.88M | -8.8% |
| Long-term debt | $46.48M | $46.23M | $45.97M | $45.09M | $44.22M | +0.5% |
| Total debt | $48.53M | $48.37M | $48.19M | $47.39M | $45.45M | +0.3% |
| Total liabilities | $61.21M | $62.26M | $67.01M | $64.95M | $63.38M | -1.7% |
| Retained earnings | -$74.89M | -$74.50M | -$75.30M | -$73.69M | -$43.29M | -0.5% |
| Shareholder equity | $7.94M | $7.03M | $5.94M | $6.15M | $35.40M | +13.0% |
| Working capital | $19.71M | $17.50M | $14.92M | $13.87M | $18.79M | +12.6% |
| Net tangible assets | -$12.94M | -$14.43M | -$16.30M | -$18.55M | -$9.19M | +10.4% |
| Shares issued | 9.19M | 9.17M | 8.95M | 8.93M | 8.90M | +0.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$452.86K | $458.60K | -$1.61M | -$30.41M | -$2.02M | -198.7% |
| Depreciation & amortisation | $619.11K | $587.25K | $668.40K | $1.04M | $1.11M | +5.4% |
| Stock-based compensation | $1.50M | $1.03M | $1.18M | $1.23M | $1.44M | +45.5% |
| Change in working capital | -$554.41K | -$5.50M | $408.13K | $2.28M | $662.09K | +89.9% |
| Operating cash flow | $2.04M | -$2.47M | $3.95M | $2.18M | $2.66M | +182.7% |
| Capital expenditure | -$5.28K | -$43.77K | -$82.16K | -$1.06M | -$1.78M | +87.9% |
| Investing cash flow | -$5.28K | -$43.77K | -$2.45M | -$3.42M | -$3.93M | +87.9% |
| Financing cash flow | -$206.48K | -$475.22K | $139.43K | -$774.75K | -$2.47M | +56.6% |
| Free cash flow | $2.03M | -$2.51M | $3.86M | $1.12M | $879.20K | +181.0% |
| End cash position | $15.42M | $13.59M | $16.58M | $14.94M | $16.96M | +13.4% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.07 | 0.09 | +223.1% |
| Mar 2026 | -0.22 | 0.04 | +118.2% |
| Dec 2025 | 0.11 | -0.19 | -272.7% |
| Sep 2025 | -0.22 | -3.52 | -1,537.2% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.02 | 1 | $29.50M | +12.0% |
| Next quarter | 0.18 | 1 | $31.20M | +13.3% |
| Current year | 0.20 | 1 | $116.60M | +13.1% |
| Next year | 0.54 | 1 | $133.19M | +14.2% |
Analyst targets & ownership
Mean target$35.00
High target$35.00
Low target$35.00
Implied upside-0.23%
Analyst count3
ConsensusNONE
Strong buy / Buy0 / 0
Hold3
Sell / Strong sell0 / 0
Held by insiders47.94%
Held by institutions20.02%
Institutions holding115
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
35.03
+0.14% from price
SMA 20
35.05
+0.07% from price
SMA 50
34.58
+1.46% from price
SMA 100
28.99
+21.00% from price
SMA 200
24.67
+42.20% from price
EMA 12
35.02
+0.17% from price
EMA 26
34.73
+1.02% from price
EMA 50
33.28
+5.39% from price
RSI (14)
63.9
Neutral
MACD (12,26,9)
0.29
Hist -0.13
ATR (14)
0.20
0.56% of price
Realised vol 30D
5.3%
Annualised
Bollinger upper
35.25
20, 2σ
Bollinger lower
34.85
20, 2σ
50 / 200 cross
Golden
34.58 vs 24.67
Trend bias
Above 200
+42.20%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.66
Less volatile than market
Correlation to SPY
0.15
Largely independent
Realised vol 30D
5.3%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-49.5%
Peak to trough
Max drawdown 5Y
-67.1%
Peak to trough
ATR 14
0.20
0.56% of price
Beta (reported)
1.19
5Y monthly, from filing
Short interest
Shares short
310.03K
Prior 211.13K
Change vs prior
+46.8%
Shorts adding
% of float
5.80%
Normal
% of shares out
3.37%
Against total outstanding
Days to cover
1.0
Liquid
Float
3.77M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 30, 26 | HC Wainwright & Co. | DOWNGRADE | Buy | Neutral |
| Jun 17, 26 | Freedom Broker | INITIATED | — | Buy |
| Apr 15, 26 | Lake Street | INITIATED | — | Buy |
| Jan 26, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Nov 14, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Aug 18, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| May 15, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Mar 26, 25 | Cantor Fitzgerald | MAINTAINED | Overweight | Overweight |
| Mar 26, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jan 23, 25 | Cantor Fitzgerald | MAINTAINED | Overweight | Overweight |
| Jan 23, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jan 22, 25 | Cantor Fitzgerald | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay dateMay 10, 2019
Last split1:100
Split dateMay 10, 2019
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-10-01
Proxy Statements
DEFM14A · 2026-09-04
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425 · 2026-08-20
Corporate Changes & Voting Matters
8-K/A · 2026-08-11
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425 · 2026-07-30
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425 · 2026-07-29
Corporate Changes & Voting Matters
8-K · 2026-06-09
Corporate Changes & Voting Matters
8-K · 2026-06-04
Headlines
Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates
Zacks · 57d ago
Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)
GlobeNewswire · 57d ago
MiMedx (MDXG) Q2 2026 Earnings Call Transcript
Motley Fool · 61d ago
biote Corp. (BTMD) Reports Break-Even Earnings for Q2
Zacks · 63d ago
MiMedx Group Inc (MDXG) (Q2 2026) Earnings Call Highlights: Surgical Growth and Transformative ...
GuruFocus.com · 70d ago
MiMedx Group Q2 Earnings Call Highlights
MarketBeat · 70d ago
MIMEDX Announces Second Quarter 2026 Operating & Financial Results
GlobeNewswire · 70d ago
MIMEDX to Acquire Sanara MedTech
GlobeNewswire · 70d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.